New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

The Challenge of SARS-CoV-2 Variants The emergence of the SARS-CoV-2 variants B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351) and P.1 (B.1.1.28.1) has aroused many concerns, including worsening Covid-19 and escape from vaccine-induced immunity.

Automated summary

The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.